Boost your vitality and take control of your well-being today
Whether you need guidance on portion control, healthy meal options, or strategies for managing cravings, our customized meal plans offer the support and structure you need to succeed
Exp: 04/26 Original price was: 4,980.Current price is: 2,980
Finally, some investors and analysts have suggested that Viking could be a takeover target -- this could be another route to gains.
Any pen that has been frozen must be discarded immediately, even if it appears normal, as freezing causes irreversible changes that cannot be detected by visual inspection

Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products